Anti–Oral Mucositis Drug Market, Global Outlook and Forecast 2022-2028

February 2022 | 67 pages | ID: A66F7550B0C4EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Anti–Oral Mucositis Drug in Global, including the following market information:

Global Anti–Oral Mucositis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti–Oral Mucositis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Mouthwash Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti–Oral Mucositis Drug include 3M Healthcare, GSK, Pfizer, Colgate-Palmolive, Norgine, Biovitrum, Bausch Health, EUSA Pharma and Camurus, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti–Oral Mucositis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti–Oral Mucositis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti–Oral Mucositis Drug Market Segment Percentages, by Type, 2021 (%)

• Mouthwash
• Pain Control Medication
• Other

Global Anti–Oral Mucositis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti–Oral Mucositis Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Anti–Oral Mucositis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti–Oral Mucositis Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti–Oral Mucositis Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti–Oral Mucositis Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• 3M Healthcare
• GSK
• Pfizer
• Colgate-Palmolive
• Norgine
• Biovitrum
• Bausch Health
• EUSA Pharma
• Camurus
• Mission Pharmacal
• Clinigen Group
• Midatech Pharma
• Alliance Pharma
• AMAG Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti–Oral Mucositis Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti–Oral Mucositis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI–ORAL MUCOSITIS DRUG OVERALL MARKET SIZE

2.1 Global Anti–Oral Mucositis Drug Market Size: 2021 VS 2028
2.2 Global Anti–Oral Mucositis Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti–Oral Mucositis Drug Players in Global Market
3.2 Top Global Anti–Oral Mucositis Drug Companies Ranked by Revenue
3.3 Global Anti–Oral Mucositis Drug Revenue by Companies
3.4 Top 3 and Top 5 Anti–Oral Mucositis Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti–Oral Mucositis Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti–Oral Mucositis Drug Players in Global Market
  3.6.1 List of Global Tier 1 Anti–Oral Mucositis Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti–Oral Mucositis Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti–Oral Mucositis Drug Market Size Markets, 2021 & 2028
  4.1.2 Mouthwash
  4.1.3 Pain Control Medication
  4.1.4 Other
4.2 By Type - Global Anti–Oral Mucositis Drug Revenue & Forecasts
  4.2.1 By Type - Global Anti–Oral Mucositis Drug Revenue, 2017-2022
  4.2.2 By Type - Global Anti–Oral Mucositis Drug Revenue, 2023-2028
  4.2.3 By Type - Global Anti–Oral Mucositis Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti–Oral Mucositis Drug Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Other
5.2 By Application - Global Anti–Oral Mucositis Drug Revenue & Forecasts
  5.2.1 By Application - Global Anti–Oral Mucositis Drug Revenue, 2017-2022
  5.2.2 By Application - Global Anti–Oral Mucositis Drug Revenue, 2023-2028
  5.2.3 By Application - Global Anti–Oral Mucositis Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti–Oral Mucositis Drug Market Size, 2021 & 2028
6.2 By Region - Global Anti–Oral Mucositis Drug Revenue & Forecasts
  6.2.1 By Region - Global Anti–Oral Mucositis Drug Revenue, 2017-2022
  6.2.2 By Region - Global Anti–Oral Mucositis Drug Revenue, 2023-2028
  6.2.3 By Region - Global Anti–Oral Mucositis Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti–Oral Mucositis Drug Revenue, 2017-2028
  6.3.2 US Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.3.3 Canada Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.3.4 Mexico Anti–Oral Mucositis Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti–Oral Mucositis Drug Revenue, 2017-2028
  6.4.2 Germany Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.4.3 France Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.4.4 U.K. Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.4.5 Italy Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.4.6 Russia Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.4.8 Benelux Anti–Oral Mucositis Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti–Oral Mucositis Drug Revenue, 2017-2028
  6.5.2 China Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.5.3 Japan Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.5.4 South Korea Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.5.6 India Anti–Oral Mucositis Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti–Oral Mucositis Drug Revenue, 2017-2028
  6.6.2 Brazil Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.6.3 Argentina Anti–Oral Mucositis Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti–Oral Mucositis Drug Revenue, 2017-2028
  6.7.2 Turkey Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.7.3 Israel Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti–Oral Mucositis Drug Market Size, 2017-2028
  6.7.5 UAE Anti–Oral Mucositis Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 3M Healthcare
  7.1.1 3M Healthcare Corporate Summary
  7.1.2 3M Healthcare Business Overview
  7.1.3 3M Healthcare Anti–Oral Mucositis Drug Major Product Offerings
  7.1.4 3M Healthcare Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.1.5 3M Healthcare Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Anti–Oral Mucositis Drug Major Product Offerings
  7.2.4 GSK Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.2.5 GSK Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Anti–Oral Mucositis Drug Major Product Offerings
  7.3.4 Pfizer Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Colgate-Palmolive
  7.4.1 Colgate-Palmolive Corporate Summary
  7.4.2 Colgate-Palmolive Business Overview
  7.4.3 Colgate-Palmolive Anti–Oral Mucositis Drug Major Product Offerings
  7.4.4 Colgate-Palmolive Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.4.5 Colgate-Palmolive Key News
7.5 Norgine
  7.5.1 Norgine Corporate Summary
  7.5.2 Norgine Business Overview
  7.5.3 Norgine Anti–Oral Mucositis Drug Major Product Offerings
  7.5.4 Norgine Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.5.5 Norgine Key News
7.6 Biovitrum
  7.6.1 Biovitrum Corporate Summary
  7.6.2 Biovitrum Business Overview
  7.6.3 Biovitrum Anti–Oral Mucositis Drug Major Product Offerings
  7.6.4 Biovitrum Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.6.5 Biovitrum Key News
7.7 Bausch Health
  7.7.1 Bausch Health Corporate Summary
  7.7.2 Bausch Health Business Overview
  7.7.3 Bausch Health Anti–Oral Mucositis Drug Major Product Offerings
  7.7.4 Bausch Health Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.7.5 Bausch Health Key News
7.8 EUSA Pharma
  7.8.1 EUSA Pharma Corporate Summary
  7.8.2 EUSA Pharma Business Overview
  7.8.3 EUSA Pharma Anti–Oral Mucositis Drug Major Product Offerings
  7.8.4 EUSA Pharma Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.8.5 EUSA Pharma Key News
7.9 Camurus
  7.9.1 Camurus Corporate Summary
  7.9.2 Camurus Business Overview
  7.9.3 Camurus Anti–Oral Mucositis Drug Major Product Offerings
  7.9.4 Camurus Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.9.5 Camurus Key News
7.10 Mission Pharmacal
  7.10.1 Mission Pharmacal Corporate Summary
  7.10.2 Mission Pharmacal Business Overview
  7.10.3 Mission Pharmacal Anti–Oral Mucositis Drug Major Product Offerings
  7.10.4 Mission Pharmacal Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.10.5 Mission Pharmacal Key News
7.11 Clinigen Group
  7.11.1 Clinigen Group Corporate Summary
  7.11.2 Clinigen Group Business Overview
  7.11.3 Clinigen Group Anti–Oral Mucositis Drug Major Product Offerings
  7.11.4 Clinigen Group Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.11.5 Clinigen Group Key News
7.12 Midatech Pharma
  7.12.1 Midatech Pharma Corporate Summary
  7.12.2 Midatech Pharma Business Overview
  7.12.3 Midatech Pharma Anti–Oral Mucositis Drug Major Product Offerings
  7.12.4 Midatech Pharma Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.12.5 Midatech Pharma Key News
7.13 Alliance Pharma
  7.13.1 Alliance Pharma Corporate Summary
  7.13.2 Alliance Pharma Business Overview
  7.13.3 Alliance Pharma Anti–Oral Mucositis Drug Major Product Offerings
  7.13.4 Alliance Pharma Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.13.5 Alliance Pharma Key News
7.14 AMAG Pharmaceuticals
  7.14.1 AMAG Pharmaceuticals Corporate Summary
  7.14.2 AMAG Pharmaceuticals Business Overview
  7.14.3 AMAG Pharmaceuticals Anti–Oral Mucositis Drug Major Product Offerings
  7.14.4 AMAG Pharmaceuticals Anti–Oral Mucositis Drug Revenue in Global Market (2017-2022)
  7.14.5 AMAG Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti–Oral Mucositis Drug Market Opportunities & Trends in Global Market
Table 2. Anti–Oral Mucositis Drug Market Drivers in Global Market
Table 3. Anti–Oral Mucositis Drug Market Restraints in Global Market
Table 4. Key Players of Anti–Oral Mucositis Drug in Global Market
Table 5. Top Anti–Oral Mucositis Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti–Oral Mucositis Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti–Oral Mucositis Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti–Oral Mucositis Drug Product Type
Table 9. List of Global Tier 1 Anti–Oral Mucositis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti–Oral Mucositis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti–Oral Mucositis Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti–Oral Mucositis Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti–Oral Mucositis Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti–Oral Mucositis Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti–Oral Mucositis Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti–Oral Mucositis Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2023-2028
Table 30. 3M Healthcare Corporate Summary
Table 31. 3M Healthcare Anti–Oral Mucositis Drug Product Offerings
Table 32. 3M Healthcare Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 33. GSK Corporate Summary
Table 34. GSK Anti–Oral Mucositis Drug Product Offerings
Table 35. GSK Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Anti–Oral Mucositis Drug Product Offerings
Table 38. Pfizer Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 39. Colgate-Palmolive Corporate Summary
Table 40. Colgate-Palmolive Anti–Oral Mucositis Drug Product Offerings
Table 41. Colgate-Palmolive Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 42. Norgine Corporate Summary
Table 43. Norgine Anti–Oral Mucositis Drug Product Offerings
Table 44. Norgine Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 45. Biovitrum Corporate Summary
Table 46. Biovitrum Anti–Oral Mucositis Drug Product Offerings
Table 47. Biovitrum Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 48. Bausch Health Corporate Summary
Table 49. Bausch Health Anti–Oral Mucositis Drug Product Offerings
Table 50. Bausch Health Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 51. EUSA Pharma Corporate Summary
Table 52. EUSA Pharma Anti–Oral Mucositis Drug Product Offerings
Table 53. EUSA Pharma Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 54. Camurus Corporate Summary
Table 55. Camurus Anti–Oral Mucositis Drug Product Offerings
Table 56. Camurus Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 57. Mission Pharmacal Corporate Summary
Table 58. Mission Pharmacal Anti–Oral Mucositis Drug Product Offerings
Table 59. Mission Pharmacal Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 60. Clinigen Group Corporate Summary
Table 61. Clinigen Group Anti–Oral Mucositis Drug Product Offerings
Table 62. Clinigen Group Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 63. Midatech Pharma Corporate Summary
Table 64. Midatech Pharma Anti–Oral Mucositis Drug Product Offerings
Table 65. Midatech Pharma Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 66. Alliance Pharma Corporate Summary
Table 67. Alliance Pharma Anti–Oral Mucositis Drug Product Offerings
Table 68. Alliance Pharma Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)
Table 69. AMAG Pharmaceuticals Corporate Summary
Table 70. AMAG Pharmaceuticals Anti–Oral Mucositis Drug Product Offerings
Table 71. AMAG Pharmaceuticals Anti–Oral Mucositis Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti–Oral Mucositis Drug Segment by Type in 2021
Figure 2. Anti–Oral Mucositis Drug Segment by Application in 2021
Figure 3. Global Anti–Oral Mucositis Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti–Oral Mucositis Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti–Oral Mucositis Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti–Oral Mucositis Drug Revenue in 2021
Figure 8. By Type - Global Anti–Oral Mucositis Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti–Oral Mucositis Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti–Oral Mucositis Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti–Oral Mucositis Drug Revenue Market Share, 2017-2028
Figure 12. US Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti–Oral Mucositis Drug Revenue Market Share, 2017-2028
Figure 16. Germany Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti–Oral Mucositis Drug Revenue Market Share, 2017-2028
Figure 24. China Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti–Oral Mucositis Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti–Oral Mucositis Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti–Oral Mucositis Drug Revenue, (US$, Mn), 2017-2028
Figure 37. 3M Healthcare Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GSK Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Colgate-Palmolive Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Norgine Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Biovitrum Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bausch Health Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. EUSA Pharma Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Camurus Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Mission Pharmacal Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Clinigen Group Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Midatech Pharma Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Alliance Pharma Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. AMAG Pharmaceuticals Anti–Oral Mucositis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)